Works by Yoshimura, Tomoaki

Results: 63

Comment on: 'Effects of age, sex, daily dose, comorbidity and co‐medication on venlafaxine‐associated cardiovascular adverse events: A pharmacovigilance analysis of the FDA adverse event reporting system database'.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 6, p. 1873, doi. 10.1111/bcp.70089

By:

Masuda, Rikuto;
Noguchi, Yoshihiro;
Kobayashi, Ryo;
Yoshimura, Tomoaki

Publication type:

Article

Influences of dispersion media for chemically modified cellulose nanofibers on rheological and mechanical properties of cellulose nanofiber reinforced high-density polyethylene.

Published in:

Cellulose, 2021, v. 28, n. 8, p. 4719, doi. 10.1007/s10570-021-03824-8

By:

Sato, Akihiro;
Yoshimura, Tomoaki;
Kabusaki, Daisuke;
Okumura, Hiroaki;
Homma, Yoko;
Sano, Hironari;
Nakatsubo, Fumiaki;
Kuboki, Takashi;
Yano, Hiroyuki

Publication type:

Article

Quality of life assessment and cost‑utility analysis of initial chemotherapy for patients with non‑Hodgkin's lymphoma: A prospective analysis.

Published in:

Oncology Letters, 2024, v. 28, n. 3, p. N.PAG, doi. 10.3892/ol.2024.14564

By:

Tanaka, Kazuhide;
Yasuda, Masahiro;
Tachi, Tomoya;
Teshigawara, Yuta;
Inoue, Seiji;
Ino, Yoko;
Kitagawa, Junichi;
Noguchi, Yoshihiro;
Yoshimura, Tomoaki;
Teramachi, Hitomi;
Kasahara, Senji

Publication type:

Article

Evaluation of the therapeutic effects and tolerability of modified lenvatinib administration methods for unresectable hepatocellular carcinoma: A preliminary study.

Published in:

Oncology Letters, 2023, v. 25, n. 4, p. N.PAG, doi. 10.3892/ol.2023.13736

By:

Kimura, Michio;
Go, Makiko;
Yamada, Shiori;
Asano, Hiroki;
Usami, Eiseki;
Yoshimura, Tomoaki

Publication type:

Article

Elucidation of optimal proteinuria management based on the risk of ramucirumab-induced proteinuria.

Published in:

Oncology Letters, 2022, v. 23, n. 2, p. N.PAG

By:

Kimura, Michio;
Usami, Eiseki;
Teramachi, Hitomi;
Yoshimura, Tomoaki

Publication type:

Article

Adherence and awareness of the therapeutic intent of oral anticancer agents in an outpatient setting.

Published in:

Oncology Letters, 2015, v. 9, n. 5, p. 2341, doi. 10.3892/ol.2015.3027

By:

MICHIO KIMURA;
KEIJI NAKASHIMA;
EISEKI USAMI;
MINA IWAI;
TOSHIYA NAKAO;
TOMOAKI YOSHIMURA;
HIROMI MORI;
HITOMI TERAMACHI

Publication type:

Article

Oral anticancer agent medication adherence by outpatients.

Published in:

Oncology Letters, 2014, v. 8, n. 5, p. 2318, doi. 10.3892/ol.2014.2480

By:

MICHIO KIMURA;
EISEKI USAMI;
MINA IWAI;
TOSHIYA NAKAO;
TOMOAKI YOSHIMURA;
HIROMI MORI;
TADASHI SUGIYAMA;
HITOMI TERAMACHI

Publication type:

Article

A comparative study of nivolumab and axitinib in terms of overall survival, treatment continuation, and cost for patients with metastatic renal cell carcinoma.

Published in:

Molecular & Clinical Oncology, 2020, v. 12, n. 3, p. 284, doi. 10.3892/mco.2020.1978

By:

Kimura, Michio;
Usami, Eiseki;
Teramachi, Hitomi;
Yoshimura, Tomoaki

Publication type:

Article

Tolerability and safety of real-world use of pomalidomide in patients with relapsed/refractory multiple myeloma.

Published in:

Molecular & Clinical Oncology, 2019, v. 10, n. 2, p. 293

By:

Usami, Eiseki;
Kimura, Michio;
Takenaka, Shoya;
Iwai, Mina;
Teramachi, Hitomi;
Yoshimura, Tomoaki

Publication type:

Article

Effect of the timing of discontinuation of last-line chemotherapy on patient prognosis in advanced and recurrent gastric cancer.

Published in:

Molecular & Clinical Oncology, 2019, v. 10, n. 1, p. 173

By:

Kimura, Michio;
Kawachi, Shiori;
Go, Makiko;
Iwai, Mina;
Usami, Eiseki;
Teramachi, Hitomi;
Yoshimura, Tomoaki

Publication type:

Article

Usefulness of a pharmacist outpatient service for S-1 adjuvant chemotherapy in patients with gastric cancer.

Published in:

Molecular & Clinical Oncology, 2017, v. 7, n. 3, p. 486, doi. 10.3892/mco.2017.1337

By:

MICHIO KIMURA;
MAKIKO GO;
MINA IWAI;
EISEKI USAMI;
HITOMI TERAMACHI;
TOMOAKI YOSHIMURA

Publication type:

Article

Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer.

Published in:

Molecular & Clinical Oncology, 2017, v. 7, n. 1, p. 125, doi. 10.3892/mco.2017.1278

By:

MACHIKO KURIMOTO;
MICHIO KIMURA;
EISEKI USAMI;
MINA IWAI;
TATSUYA HIROSE;
SHIORI KAWACHI;
TOMOAKI YOSHIMURA

Publication type:

Article

Analysis of the incidence of tumor lysis syndrome in patients with hematological malignancies treated with rasburicase.

Published in:

Molecular & Clinical Oncology, 2017, v. 6, n. 6, p. 955, doi. 10.3892/mco.2017.1232

By:

USAMI, EISEKI;
KIMURA, MICHIO;
IWAI, MINA;
TERAMACHI, HITOMI;
YOSHIMURA, TOMOAKI

Publication type:

Article

Pharmaco-economic analysis of adjuvant chemotherapy for stage II and III colorectal cancer.

Published in:

Molecular & Clinical Oncology, 2017, v. 6, n. 5, p. 794, doi. 10.3892/mco.2017.1218

By:

MINA IWAI;
MICHIO KIMURA;
EISEKI USAMI;
TOMOAKI YOSHIMURA;
HITOMI TERAMACHI

Publication type:

Article

Comparison of cost-effectiveness of regorafenib and trifluridine/tipiracil combination tablet for treating advanced and recurrent colorectal cancer.

Published in:

Molecular & Clinical Oncology, 2016, v. 5, n. 5, p. 635, doi. 10.3892/mco.2016.1020

By:

MICHIO KIMURA;
EISEKI USAMI;
MINA IWAI;
MAKIKO GO;
HITOMI TERAMACHI;
TOMOAKI YOSHIMURA

Publication type:

Article

Neutropenia as a prognostic factor and safety of second‑line therapy with S‑1 for advanced or recurrent pancreatic cancer.

Published in:

Molecular & Clinical Oncology, 2016, v. 5, n. 3, p. 283, doi. 10.3892/mco.2016.940

By:

MAKIKO IKAGAWA;
MICHIO KIMURA;
MINA IWAI;
EISEKI USAMI;
TOMOAKI YOSHIMURA;
KIMIO YASUDA

Publication type:

Article

Chemotherapy continuity and incidence of febrile neutropenia with CHOP therapy in an outpatient setting.

Published in:

Molecular & Clinical Oncology, 2016, v. 4, n. 4, p. 591, doi. 10.3892/mco.2016.738

By:

EISEKI USAMI;
MICHIO KIMURA;
MINA IWAI;
SHOYA TAKENAKA;
HITOMI TERAMACHI;
TOMOAKI YOSHIMURA

Publication type:

Article

Comment on: "Drug-associated kidney injury in children: a disproportionality analysis of the FDA adverse event reporting system".

Published in:

European Journal of Pediatrics, 2024, v. 183, n. 2, p. 975, doi. 10.1007/s00431-023-05265-w

By:

Noguchi, Yoshihiro;
Yoshimura, Tomoaki

Publication type:

Article

Comment: Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting System.

Published in:

2023

By:

Noguchi, Yoshihiro;
Yoshimura, Tomoaki

Publication type:

Letter to the Editor

Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database.

Published in:

Medicina (1010660X), 2023, v. 59, n. 11, p. 1963, doi. 10.3390/medicina59111963

By:

Asano, Hiroki;
Noguchi, Yoshihiro;
Kimura, Michio;
Usami, Eiseki;
Yoshimura, Tomoaki

Publication type:

Article

Allelic imbalance in chromosome band 18q21 and SMAD4 mutations in ovarian cancers.

Published in:

Genes, Chromosomes & Cancer, 1999, v. 24, n. 3, p. 264, doi. 10.1002/(SICI)1098-2264(199903)24:3<264::AID-GCC12>3.0.CO;2-Y

By:

Takakura, Satoshi;
Okamoto, Aikou;
Saito, Misato;
Yasuhara, Takaomi;
Shinozaki, Hideo;
Isonishi, Seiji;
Yoshimura, Tomoaki;
Ohtake, Yasuyuki;
Ochiai, Kazunori;
Tanaka, Tadao

Publication type:

Article

Inhibition of Tumor Necrosis Factor-Alpha and lnterleukin-1-Beta Production by Beta-Adrenoceptor Agonists from Lipopolysaccharide- Stimulated Human Peripheral Blood Mononuclear Cells.

Published in:

Pharmacology, 1997, v. 54, n. 3, p. 144, doi. 10.1159/000139481

By:

Yoshimura, Tomoaki;
Kurita, Chikako;
Nagao, Tomomi;
Usami, Eiseki;
Nakao, Toshiya;
Watanabe, Shino;
Kobayashi, Joji;
Yamazaki, Futoshi;
Tanaka, Hiroyuki;
Inagaki, Naoki;
Nagai, Hiroich

Publication type:

Article

Assessment of Cardiovascular Events Caused by New-Generation Androgen Receptor Pathway Inhibitors Used for Prostate Cancer: A Real-World Study in Japan.

Published in:

Oncology, 2025, v. 103, n. 2, p. 134, doi. 10.1159/000540864

By:

Masuda, Rikuto;
Noguchi, Yoshihiro;
Aizawa, Haruka;
Yoshizawa, Shunsuke;
Nomura, Yuki;
Saguchi, Mitsuru;
Iguchi, Kazuhiro;
Yoshimura, Tomoaki

Publication type:

Article

Sleep-Prolonging Effect of Memantine for Short Periods and Low Doses.

Published in:

Neuroscience & Behavioral Physiology, 2021, v. 51, n. 7, p. 1027, doi. 10.1007/s11055-021-01161-8

By:

Mori, Koki;
Yoshida, Mitsuyo;
Tomita, Kenji;
Nakamura, Mitsuhiro;
Yoshimura, Tomoaki

Publication type:

Article

Analysis of adverse events leading to dose reduction/interruption of lenvatinib treatment in patients with Child-Pugh B unresectable hepatocellular carcinoma.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1637, doi. 10.1177/10781552221145475

By:

Kimura, Michio;
Asano, Hiroki;
Usami, Eiseki;
Teramachi, Hitomi;
Yoshimura, Tomoaki

Publication type:

Article

The incidence and timing of leukocyte overshoot after pegfilgrastim administration.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 869, doi. 10.1177/1078155218769140

By:

Usami, Eiseki;
Kimura, Michio;
Iwai, Mina;
Go, Makiko;
Asano, Hiroki;
Takenaka, Shoya;
Adachi, Shino;
Yoshimura, Tomoaki

Publication type:

Article

Cost-effectiveness and safety of ramucirumab plus paclitaxel chemotherapy in the treatment of advanced and recurrent gastric cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 6, p. 403, doi. 10.1177/1078155217707335

By:

Kimura, Michio;
Usami, Eiseki;
Teramachi, Hitomi;
Yoshimura, Tomoaki

Publication type:

Article

Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 6, p. 413, doi. 10.1177/1078155216655473

By:

Kimura, Michio;
Go, Makiko;
Iwai, Mina;
Usami, Eiseki;
Yoshimura, Tomoaki;
Teramachi, Hitomi

Publication type:

Article

Relationship between Anaplastic Lymphoma Kinase Inhibitors and Epileptic Seizure Disorder: A Post-Marketing Surveillance Study.

Published in:

Oncology, 2024, v. 102, n. 11, p. 996, doi. 10.1159/000539426

By:

Noguchi, Yoshihiro;
Asano, Hiroki;
Masuda, Rikuto;
Teshigawara, Yuta;
Go, Makiko;
Kimura, Michio;
Usami, Eiseki;
Yoshimura, Tomoaki

Publication type:

Article

Follow-up of Clinical Symptoms and Blood Concentration in Donepezil Overdose.

Published in:

Primary Care Companion for CNS Disorders (2155-7772), 2023, v. 25, n. 5, p. 1, doi. 10.4088/PCC.23cr03511

By:

Koki Mori;
Tatsuya Hirose;
Tomohiro Matsumura;
Tomoaki Yoshimura

Publication type:

Article

Effects of Pharmacist-Led Dementia Care Round Interventions on the Use of Sleep Medications.

Published in:

Primary Care Companion for CNS Disorders (2155-7772), 2022, v. 24, n. 6, p. e1, doi. 10.4088/PCC.22m03258

By:

Koki Mori;
Mitsuyo Yoshida;
Kenji Tomita;
Mitsuhiro Nakamura;
Tomoaki Yoshimura

Publication type:

Article

Influence of renal dysfunction on dose reduction and virologic efficacy of regimens combining ribavirin and all‐oral direct acting antivirals in patients with chronic hepatitis C virus infection.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 512, doi. 10.1111/hepr.13311

By:

Nakashima, Megumi;
Toyoda, Hidenori;
Tada, Toshifumi;
Mizuno, Kazuyuki;
Iio, Etsuko;
Tanaka, Yasuhito;
Sugiyama, Tadashi;
Yoshimura, Tomoaki;
Kumada, Takashi

Publication type:

Article

Safety and continuity of second- and third-line therapy with paclitaxel or irinotecan for advanced and recurrent gastric cancer.

Published in:

Molecular & Clinical Oncology, 2014, v. 2, n. 3, p. 466, doi. 10.3892/mco.2014.260

By:

MICHIO KIMURA;
EISEKI USAMI;
TETSUFUMI KANEMATSU;
MINA IWAI;
TOMOAKI YOSHIMURA;
HIROMI MORI;
TADASHI SUGIYAMA;
HITOMI TERAMACHI

Publication type:

Article

Evaluation of hypokalemia and potassium supplementation during administration of liposomal-amphotericin B.

Published in:

Experimental & Therapeutic Medicine, 2014, v. 7, n. 4, p. 941, doi. 10.3892/etm.2014.1534

By:

EISEKI USAMI;
MICHIO KIMURA;
TETSUFUMI KANEMATSU;
SHINYA YOSHIDA;
TAKAYUKI MORI;
KEIJI NAKASHIMA;
TOMOKO MATSUOKA;
TOMOAKI YOSHIMURA;
HIROMI MORI;
TADASHI SUGIYAMA;
HITOMI TERAMACHI

Publication type:

Article

Analysis of pharmacological interventions among hospitalised patients with COVID‑19: A focus on severe cases.

Published in:

Biomedical Reports, 2023, v. 18, n. 2, p. N.PAG

By:

Shinoda, Yasutaka;
Ohashi, Kengo;
Matsuoka, Tomoko;
Yoshimura, Tomoaki

Publication type:

Article

Efficacy of daiokanzoto in chronic constipation refractory to first-line laxatives.

Published in:

Biomedical Reports, 2016, v. 5, n. 4, p. 497, doi. 10.3892/br.2016.754

By:

TATSUYA HIROSE;
YASUTAKA SHINODA;
AYA YOSHIDA;
MACHIKO KURIMOTO;
KOUKI MORI;
YUKI KAWACHI;
KOUJI TANAKA;
ATSUKO TAKEDA;
TOMOAKI YOSHIMURA;
TADASHI SUGIYAMA

Publication type:

Article

Potential drug interaction between paclitaxel and clopidogrel.

Published in:

Biomedical Reports, 2016, v. 5, n. 1, p. 141, doi. 10.3892/br.2016.685

By:

Yasutaka Shinoda;
Michio Kimura;
Eiseki Usami;
Hiroki Asano;
Tomoaki Yoshimura

Publication type:

Article

Comment on: "Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database.": AEs of SGLT2 Inhibitors in DM or Heart Failure: Y. Noguchi et al

Published in:

Clinical Drug Investigation, 2025, v. 45, n. 1, p. 45, doi. 10.1007/s40261-024-01407-6

By:

Noguchi, Yoshihiro;
Suzuki, Keiko;
Ino, Yoko;
Yoshimura, Tomoaki

Publication type:

Article

Is it possible to identify risk factors for adverse drug reactions using a pharmacovigilance database based on spontaneous reporting?

Published in:

Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 1, p. 1, doi. 10.1002/pds.5737

By:

Noguchi, Yoshihiro;
Yoshimura, Tomoaki

Publication type:

Article

Comment on: Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug–drug interactions.

Published in:

Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 1, p. 1, doi. 10.1002/pds.5722

By:

Noguchi, Yoshihiro;
Yoshimura, Tomoaki

Publication type:

Article

Identifying optimal magnesium replenishment points based on risk of severe hypomagnesemia in colorectal cancer patients treated with cetuximab or panitumumab.

Published in:

Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 3, p. 383, doi. 10.1007/s00280-020-04126-9

By:

Kimura, Michio;
Usami, Eiseki;
Teramachi, Hitomi;
Yoshimura, Tomoaki

Publication type:

Article

Immunomodulatory Action of Levofloxacin on Cytokine Production by Human Peripheral Blood Mononuclear Cells.

Published in:

Chemotherapy (0009-3157), 1996, v. 42, n. 6, p. 459, doi. 10.1159/000239480

By:

Yoshimura, Tomoaki;
Kurita, Chikako;
Usami, Eiseki;
Nakao, Toshiya;
Watanabe, Shino;
Kobayashi, Joji;
Yamazaki, Futoshi;
Nagai, Hiroichi

Publication type:

Article

Clinical outcome of pharmacist-led prospective audit with intervention and feedback after expansion from patients using specific antibiotics to those using whole injectable antibiotics.

Published in:

European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 3, p. 593, doi. 10.1007/s10096-018-03465-z

By:

Ohashi, Kengo;
Matsuoka, Tomoko;
Shinoda, Yasutaka;
Mori, Takayuki;
Yoshida, Shinya;
Yoshimura, Tomoaki;
Sugiyama, Tadashi

Publication type:

Article

Analysis of drug-induced hand–foot syndrome using a spontaneous reporting system database.

Published in:

Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221101963

By:

Yoshida, Yu;
Sasaoka, Sayaka;
Tanaka, Mizuki;
Matsumoto, Kiyoka;
Inoue, Misaki;
Satake, Riko;
Shimada, Kazuyo;
Mukai, Ririka;
Suzuki, Takaaki;
Iwata, Mari;
Goto, Fumiya;
Mori, Takayuki;
Mori, Koki;
Yoshimura, Tomoaki;
Nakamura, Mitsuhiro

Publication type:

Article

Comment on: Drugs That Interact With Colchicine via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS).

Published in:

Annals of Pharmacotherapy, 2024, v. 58, n. 2, p. 196, doi. 10.1177/10600280231168858

By:

Noguchi, Yoshihiro;
Yan, Miao;
Yoshimura, Tomoaki

Publication type:

Article

Comparison of Safety and Treatment Continuity of Palbociclib and Abemaciclib for Hormone Receptor-Positive, HER2-Negative Metastatic/Recurrent Breast Cancer.

Published in:

Journal of Pharmacy Practice, 2024, v. 37, n. 6, p. 1258, doi. 10.1177/08971900241247653

By:

Go, Makiko;
Kimura, Michio;
Yamada, Shiori;
Usami, Eiseki;
Noguchi, Yoshihiro;
Yoshimura, Tomoaki

Publication type:

Article

Pharmaceutical Care for Patients Undergoing S-1 Plus Cisplatin Therapy for Unresectable Recurrent Gastric Cancer.

Published in:

2013

By:

Kimura, Michio;
Usami, Eiseki;
Yoshimura, Tomoaki;
Yasuda, Tadashi;
Kaneoka, Yuji;
Teramachi, Hitomi;
Sugiyama, Tadashi;
Tsuchiya, Teruo

Publication type:

Journal Article

Evaluation of efficacy and clinical utility of potassium peroxymonosulfate-based disinfectants.

Published in:

Canadian Journal of Infection Control / Revue Canadienne de Prévention des Infections, 2017, v. 32, n. 2, p. 93

By:

Tomoko Matsuoka;
Shinya Yoshida;
Kengo Ohashi;
Yasutaka Shinoda;
Misa Kato;
Takayuki Mori;
Tomoaki Yoshimura;
Koji Tanaka;
Ayako Sato;
Takashi Goto;
Yuko Asano;
Shiomi Ishigo;
Joe Shindo;
Yoshinori Fujimoto;
Hitomi Teramachi

Publication type:

Article

Caveats of Covariate Adjustment in Disproportionality Analysis for Best Practices: Caveats of Covariate Adjustment in Disproportionality Analysis for Best Practices: Y. Noguchi et al.

Published in:

Drug Safety, 2025, v. 48, n. 1, p. 1, doi. 10.1007/s40264-024-01473-x

By:

Noguchi, Yoshihiro;
Tachi, Tomoya;
Yoshimura, Tomoaki

Publication type:

Article

Detection Algorithms for Simple Two-Group Comparisons Using Spontaneous Reporting Systems.

Published in:

Drug Safety, 2024, v. 47, n. 6, p. 535, doi. 10.1007/s40264-024-01404-w

By:

Noguchi, Yoshihiro;
Yoshimura, Tomoaki

Publication type:

Article